In Vitro and In Vivo Evaluations of Sodium Lauryl Sulfate and Dextran Sulfate as Microbicides against Herpes Simplex and Human Immunodeficiency Viruses
- 1 January 2000
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 38 (1) , 110-9
- https://doi.org/10.1128/jcm.38.1.110-119.2000
Abstract
The efficacy of sodium lauryl sulfate (SLS), a sulfated anionic chaotropic surfactant, and dextran sulfate (DS), a polysulfated carbohydrate, against herpes simplex virus (HSV) and human immunodeficiency virus (HIV) infections was evaluated in cultured cells and in different murine models of HSV infection. Results showed that both SLS and DS were potent inhibitors of the infectivities of various HSV-1 and HSV-2 strains. Pretreatment of HIV-1 (strain NL4-3) with SLS also reduced its infectivity to 1G5 cells. DS prevented the binding of HSV to cell surface receptors and therefore its entry into cells. Pretreatment of HSV-1 (strain F) with 50 μM SLS resulted in a complete loss of virus infectivity to Vero cells. However, viruses were able to enter into cells and to produce in the nuclei capsid shells devoid of a DNA core. The amount of the glycoprotein D gene produced in these cells remained unchanged compared to controls, suggesting that SLS could interfere with the maturation of the virus. At a higher SLS concentration (100 μM), HSV was highly damaged by SLS pretreatment and only a few viral particles could enter into cells to produce abnormal capsids. Although DS was a more potent inhibitor of HSV infectivity in vitro, it was unable to provide any protection in murine models of HSV infection. However, SLS conferred a complete protection of animals infected cutaneously with pretreated viruses. In addition, skin pretreatment of mice with a polymer formulation containing SLS completely prevented the development of cutaneous lesions. More interestingly, intravaginal pretreatment of mice with SLS in a buffered solution also completely protected against lethal HSV-2 infection. Taken together, our results suggest that SLS could thus represent a candidate of choice as a microbicide to prevent the sexual transmission of HIV, HSV, and possibly other pathogens that cause sexually transmitted diseases.Keywords
This publication has 48 references indexed in Scilit:
- A Controlled Trial of Nonoxynol 9 Film to Reduce Male-to-Female Transmission of Sexually Transmitted DiseasesNew England Journal of Medicine, 1998
- Topical MicrobicidesSexually Transmitted Diseases, 1998
- Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factorJournal of General Virology, 1994
- Inter-relationship between gender relations and the HIV/AIDS epidemicAIDS, 1993
- The inhibitory effect of supermicidal agents on replication of HSV-2 and HIV-1 in-vitroJournal of Antimicrobial Chemotherapy, 1993
- Barrier contraceptive use and HIV infection among high-risk women in CameroonAIDS, 1993
- Synergistic topical therapy by acyclovir and A1110U for herpes simplex virus induced zosteriform rash in miceAntiviral Research, 1991
- Dextran Sulfate Suppression of Viruses in the HIV Family: Inhibition of Virion Binding to CD4 + CellsScience, 1988
- Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitroAntiviral Research, 1987
- Suramin Protection of T Cells in Vitro Against Infectivity and Cytopathic Effect of HTLV-IIIScience, 1984